ARTL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Artelo Biosciences Inc (ARTL) is not a good buy for a beginner, long-term investor at this time. The technical indicators are bearish, there is no positive sentiment or catalysts in the news, and the financial performance remains weak with no revenue growth. Additionally, there are no proprietary trading signals or significant trading trends to support a buy decision.
The MACD is negative and expanding, indicating bearish momentum. The RSI is at 21.985, which is in the oversold territory but does not provide a clear buy signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its support level of 1.248, with resistance levels at 1.467 and 1.687.
NULL identified. No recent news or significant insider/hedge fund activity.
is down by 1.54%, which could indicate negative sentiment.
In Q3 2025, revenue remained at $0 with no YoY growth. Net income improved to -$3.12M, up 175.62% YoY, and EPS improved to -3.96, up 88.57% YoY. However, the company is still unprofitable, and there is no clear path to revenue generation or profitability.
No analyst ratings or price target changes available.
